Skip to contentSkip to Braille Studio

Library / Laws / 118th Congress / House Bills / H.R. 2297

H.R. 2297

To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024.

Print stageDateSize⠃
Introduced in House2023-03-29841 B⠃⠗⠋